Taking lenient stance, NICE backs neuroblastoma drugBody makes special case due to rarity of the disease Share XTaking lenient stance, NICE backs neuroblastoma drughttps://pharmaphorum.com/news/taking-lenient-stance-nice-backs-neuroblastoma-drug/